Source: http://www.google.com/patents/US5434049?dq=5,941,947
Timestamp: 2017-05-27 07:17:33
Document Index: 352426254

Matched Legal Cases: ['art 1', 'art 1', 'art 2', 'art 3', 'art 1', 'art 1', 'art 11', 'art 93', 'art 94', 'art 93']

Patent US5434049 - Separation of polynucleotides using supports having a plurality of electrode ... - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsA method for simultaneously detecting a plurality of target polynucleotides in a sample on a single reaction chip and a method for separating a plurality of target polynucleotides are provided. On the reaction chip are arranged a plurality of independent cells for capturing different target polynucleotides....http://www.google.com/patents/US5434049?utm_source=gb-gplus-sharePatent US5434049 - Separation of polynucleotides using supports having a plurality of electrode-containing cellsAdvanced Patent SearchTry the new Google Patents, with machine-classified Google Scholar results, and Japanese and South Korean patents.Publication numberUS5434049 APublication typeGrantApplication numberUS 08/021,667Publication dateJul 18, 1995Filing dateFeb 24, 1993Priority dateFeb 28, 1992Fee statusLapsedAlso published asUS5607646, US5817506Publication number021667, 08021667, US 5434049 A, US 5434049A, US-A-5434049, US5434049 A, US5434049AInventorsKazunori Okano, Hideki KambaraOriginal AssigneeHitachi, Ltd.Export CitationBiBTeX, EndNote, RefManPatent Citations (4), Referenced by (347), Classifications (19), Legal Events (6) External Links: USPTO, USPTO Assignment, EspacenetSeparation of polynucleotides using supports having a plurality of electrode-containing cells
US 5434049 AAbstract
A method for simultaneously detecting a plurality of target polynucleotides in a sample on a single reaction chip and a method for separating a plurality of target polynucleotides are provided. On the reaction chip are arranged a plurality of independent cells for capturing different target polynucleotides. Different probes are immobilized onto the individual cells, and labeled probes detect the cells where the target polynucleotides are captured, thereby analyzing the species of the captured target polynucleotides. Also, the individual cells function as electrodes to elute the captured target polynucleotides therethrough, thereby separating a plurality of the target polynucleotides.
1. A method for separating polynucleotides in a sample solution comprising the steps of;immobilizing individually different probes complementary to a plurality of target polynucleotides onto a plurality of cells formed at different regions on a single polynucleotide capturing support having an electrode on a surface of each of the cells, adding the sample solution to the surface of the support and covering the surface of each cell with the sample solution, for capturing the target polynucleotides onto said polynucleotide capturing support by a hybridization reaction, and supplying an electric field onto the electrode of each cell separately to elute the hybridized target polynucleotides from the cells individually. 2. A method according to claim 1, further comprising a step wherein a capillary provided with another electrode is placed upon each of said cells and the hybridized target polynucleotide on each of said cells is eluted and collected into the capillary individually.
3. A method for separating polynucleotides in a sample solution comprising;immobilizing a plurality of different probes, complementary to a plurality of different target polynucleotides, onto surfaces of a plurality of cells, wherein each cell has only one probe immobilized on a cell surface, each cell is formed at a different region on a single polynucleotide capturing support, and each cell has an electrode on a cell surface, adding the sample solution to the polynucleotide capturing support and covering each cell surface with the sample solution, hybridizing the target polynucleotides to said probes immobilized on the polynucleotide capturing support under hybridization conditions that permit each probe to specifically hybridize to a complementary target polynucleotide, supplying an electric field to each electrode of each cell separately to separately elute the hybridized target polynucleotides from the cells individually, and recovering eluted target polynucleotides. 4. A method according to claim 3, further comprisingplacing a capillary provided with an electrode upon each of said cells before supplying the electric field to each of said cells to elute hybridized target polynucleotide from each of said cells and collecting an eluted target polynucleotide into the capillary. 5. A method according to claim 3, further comprising washing the cells with an aqueous solution to remove unhybridized polynucleotides before supplying an electric field.
The objective of the present invention relates to a diagnostic method for detecting the presence or absence of exogenous polynucleotides from viruses, rickettsias, bacteria and the like as the etiology of diseases or a polynucleotide carrying specific genetic information in organisms; a polynucleotide preparative method with relation to polynucleotide structural analysis; and a probe immobilized chip for use therefor.
Japanese Patent Laid-open No. 58-31998 discloses a method for capturing a target polynucleotide (DNA or RNA) sample on a solid phase as well as a method for detecting a target exogenous polynucleotide from bacteria, viruses and the like in blood and excretion samples. According to such methods, the polynucleotide in a sample is denatured through heating and the like into single strand, which is then immobilized on nitrocellulose membrane. After subsequently reacting the membrane with a polynucleotide probe being labeled with a radioisotope and having a nucleotide sequence complementary to the sequence of the polynucleotide of a detecting bacterium or a virus, the membrane is washed. If the polynucleotide of a bacterium or a virus is contained in the sample, the labeled polynucleotide probe associates with the polynucleotide via hybridization, and is thus left on the membrane. Detection of the associated product by autoradiography enables the determination as to whether or not the target polynucleotide is present.
S. R. Rasmussen et al. describe another method for capturing a target polynucleotide (DNA or RNA) sample on a solid phase in Analytical Biochemistry 198, 128-142(1991). According to the method, the phosphate group at 5' terminus of a polynucleotide is activated by using 1-methylimidazole and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide. Then, the polynucleotide is immobilized onto a polystyrene microplate having a secondary amine on the surface thereof. According to the method, the activated 5' terminal phosphate group reacts with the secondary amine, so that the 5' terminal side of the polynucleotide is covalently immobilized onto the microplate surface. In this example, a target oligonucleotide in a sample can be captured by using an immobilized polynucleotide. A specific oligonucleotide can be detected using a 32 P-labeled probe according to any of the methods.
According to the polynucleotide immobilization method described above, the labeled probe to be used for detection should be modified, depending on the subject. Therefore, the measurement of a plurality of subjects should require reaction supports of a number corresponding to the number of measuring subjects. It is possible to measure simultaneously several types of measuring subjects, using fluorophores of different wave lengths as the substances for labeling individual probes, but the increase in the number of measuring subjects causes difficulty in such simultaneous detection.
For the purpose of separating a captured target polynucleotide, the elution of the target polynucleotide alone is difficult because a great number of different polynucleotides are immobilized on a membrane and furthermore because the polynucleotides each are strongly immobilized according to the first conventional method. According to the method of S. R. Rasmussen et al., a support for immobilizing a polynucleotide is used as a probe for hybridizing and capturing a target polynucleotide, so that it may be easy to elute the target polynucleotide. According to the method, however, it is a polynucleotide of a specific sequence to be hybridized with the immobilized probe. Therefore, it is difficult to simultaneously separate a plurality of target oligonucleotides from a supporting well. It is needless to say that a plurality of target polynucleotides can be obtained by a method comprising modifying eluting conditions under ambiguous hybridization conditions. According to such method, however, the separation should be done under unstable conditions, resulting in unsatisfactory separation potency in some cases and ready exposure to the influence of sample state, which frequently causes complex conditioning. Also, it is difficult to separate target oligonucleotides of totally different sequences from each other.
It is an objective of the present invention to provide a polynucleotide capturing chip capable of simultaneously capturing a plurality of target polynucleotides, and also to provide a method for detecting a plurality of polynucleotides using the same and a method for separating a plurality of target polynucleotides.
In the polynucleotide capturing chip with immobilized probes complementary to target polynucleotides in accordance with the present invention, individually different probes for a plurality of target polynucleotides are independently immobilized on cells formed on different regions on a single chip.
In the method for detecting polynucleotides comprising a process of capturing target polynucleotides attached with a labeling substance onto a polynucleotide capturing support with immobilized probes complementary for the target polynucleotides or comprising a process of capturing target polynucleotides and a process of bonding a labeling substance, a plurality of target polynucleotides are measured using the aforementioned polynucleotide capturing chip as the polynucleotide capturing support.
According to the target polynucleotide separation method comprising capturing target polynucleotides with a polynucleotide capturing support with immobilized probes complementary for the target polynucleotides and then separating the target polynucleotides, each cell of the polynucleotide capturing chip to be used as the polynucleotide capturing support also functions as an electrode for eluting the target polynucleotides, wherein the electric fields applied to such electrodes each with a plurality of immobilized probes can be switched over one by one to elute and separate a plurality of the target polynucleotides.
The present invention for the purpose of simultaneously analyzing and separating a plurality of target polynucleotides is firstly characterized in that a plurality of independent regions for capturing different target polynucleotides are arranged on a single reaction chip, which is of particular interest. FIG. 1 depicts the general view of the reaction chip in accordance with the present invention, wherein reaction part 1 is composed of a plurality of cells, 11 to n, and individually different polynucleotide probes are immobilized in the individual cells. Through the reaction under hybridization conditions after the addition of a sample solution, the target polynucleotides contained in the sample are captured onto the reaction chip. Then, the individual target polynucleotides are captured onto different cells with the immobilized individual polynucleotide probes in accordance with the present invention. For the simultaneous analysis of the target polynucleotides, the labeled substances captured onto the individual cells can be measured using the labeled probes.
For the separation of the target polynucleotides, the target polynucleotides captured onto the individual cells are sequentially eluted. Herein, a problem occurs in that because the individual cells are adjacent to each other, the target polynucleotides captured onto the individual cells may be contaminated with each other. Secondly, the present invention is characterized in the method for eluting target polynucleotides. The target polynucleotides captured onto the chip via hybridization reaction are readily eluted via heating and the like. The present invention is constituted, as is shown in FIG. 6, such that an electric field can be applied sequentially to individual cells so as to elute a target polynucleotide captured onto each of the cells. In a cell applied with a positive electric field, the addition of a heated eluent by Joule's heat cannot trigger the elution of the target polynucleotide because of the negative charge thereof. If the electric field applied to the cell is switched to negative, the target polynucleotide is eluted via electrostatic repulsion. The sequential switch-over of the electric field regarding all the cells one by one enables the elution and recovery of different target polynucleotides captured onto a plurality of the cells without contamination. It should be required to set up a means for immediately recovering eluted target polynucleotides for preventing the recapturing of the once eluted target polynucleotide onto other cells. This can be accomplished by placing, in a cell intended for separation, a capillary tube with a positive electrode and recapturing the eluted target polynucleotides into the tube.
When such polynucleotide probe capable of complementary bonding to such target polynucleotide reacts with the target polynucleotide under hybridization conditions, a hybrid between the two types of the polynucleotides, namely the target polynucleotide and the probe, is formed. Only if the polynucleotide probe is immobilized onto a chip, the target polynucleotide should be captured onto the chip. In accordance with the present invention, it is required to arrange a plurality of cells on a chip. Therefore, such chip is preferably glass and silicon wafer having plane surface or optically plane plastics. Cells can be formed readily on silicon wafer using a photoresist for use in the semiconductor process as shown in examples. Therefore, silicon wafer is particularly useful. That is, so as to immobilize different probes for a plurality of target polynucleotides, it is required to separately activate each of the cells and to immobilize the probes. By sequentially exposing the individual cells using positive-type photoresists, then removing the resists to activate the surfaces, different probes can be immobilized onto appropriate cells.
For the detection of the target polynucleotide captured onto each of the cells, a second probe labeled with fluorophore and the like may successfully be used. The target polynucleotide is bonded, in a sandwich manner, in between the capturing probe immobilized onto each of the cells and the labeled probe, so that each of the cells immobilizes the labeled probe at an amount corresponding to the amount of the target polynucleotide. Thus, the measurement of the intensity of fluorescence gives the information of the amount of the captured target polynucleotide.
For the separation of the target polynucleotide captured onto each of the cells, the increase in temperature causes the separation of the target polynucleotide from the probe. The addition of a high concentration of a quarternary ammonium salt such as tetraethylammonium chloride can set the elution temperature of the target polynucleotide at a nearly constant temperature. Thus, it is possible to recover the captured target polynucleotide if heating is effected at a predetermined temperature. As has been described above, a plurality of target polynucleotides can be recovered without contamination, by switching the electric field applied to a cell on the reaction chip.
FIG. 1 is a plan view schematically depicting the reaction chip as one embodiment of the present invention;
FIG. 2 is a general view depicting the fluorescence measuring device of the present invention;
FIG. 3 is a schematic view depicting the state when reaction is completed in the reaction chip;
FIG. 4 is a view depicting the results of fluorescence measurement;
FIG. 5 is an enlarged plan view schematically depicting the reaction part in accordance with the present invention; and
FIG. 6 is a cross sectional view depicting the general constitution of the recovery and separation method of target polynucleotides in accordance with the present invention.
The present invention will now be explained in examples.
The polynucleotides to be used in the present examples are as follows:
polynucleotide having a nucleotide sequence, Sequence No. 1; Probe No. 1;
polynucleotide having a nucleotide sequence, Sequence No. 2; Probe No. 2;
polynucleotide having a nucleotide sequence, Sequence No. 3; Probe No. 3;
polynucleotide having a nucleotide sequence, Sequence No. 4; Probe No. 4;
polynucleotide having a nucleotide sequence, Sequence No. 5; Probe No. 5;
polynucleotide having a nucleotide sequence, Sequence No. 6; Probe No. 6.
In the present Example, explanation will follow regarding a method for preparing a reaction chip having a plurality of independent cells with immobilized different polynucleotide probes within the single reaction chip; and a method for detecting target polynucleotides using the same.
The polynucleotides of Sequence Nos. 1 and 2 are the probes for capturing λ-phage DNA as the target polynucleotide; the polynucleotides of Sequences Nos. 3 and 4 are the probes for capturing M13 phage also as the target polynucleotide. The probes are used after the immobilization onto a reaction chip comprising silicon wafer, as shown in FIG. 1. The reaction chip comprises reaction part 1 with individually immobilized probes, addition part 2 of samples, labeled probes and the like, and a reaction residual solution discharge part 3, and is of a structure where a solution is retained with preferential bank 4 composed of fluorinated ethylene resin. The reaction part 1 comprises cells 11, 12, 13, 14, - - - n-1, n, capable of immobilizing different probes, and in a first example of the chip of the present Example, probes 1, 2, 3 and 4 are immobilized onto the cells 11, 12, 13 and 14, respectively. The reaction part can be arranged two-dimensionally if the arrangement thereof in one row is not enough, so that types of probes capable of immobilization can optionally be increased. The immobilization of each probe onto the reaction part 1 of the reaction chip is carried out by the following procedures. Firstly, the surface of silicon wafer is vapor oxidized, followed by formation of fluorinated ethylene resin bank 4. The vapor oxidation herein is inevitable for the next process for preparing the surface into an aminosilane form, but it is not required to form such a thick oxidized layer as required for the formation of an insulation film during routine semiconductor processes. Then, 3-(2-aminoethylaminopropyl)trimethoxy silane is used to prepare the surface of the oxidized film into an aminosilane form to introduce the amino group into the surface of the silicon wafer. The amino group is then trifluoroacetylated for protection.
Subsequently, a quinone diazide added phenolnovolak resist of positive type is coated on the surface, which is then baked at 95° C. Because the exposed portions of the resist can be removed in alkaline washing, the repetition of the processes, namely exposure, alkaline washing, removal of trifluoroacetyl group and immobilization of a polynucleotide probe, enables sequential immobilization of individually different probes onto different regions on the silicon wafer. Firstly, the part 11 of the silicon wafer surface is exposed to the light of 350 nm to 400 nm, thereby removing the resist on cell 11. Subsequently, washing is effected in an aqueous trimethylammonium solution, to remove the decomposed resist. Concurrently, the amino group protecting trifluoroacetyl group is also removed. According to the method of S. R. Rasmussen et al. described in Analytical Biochemistry, Vol. 198, 128-142(1991), a first probe having a phosphate group at 5' terminus is immobilized. That is, the first probe is subjected to reaction in the presence of 1-methyl imidazole buffer, pH 7.0 and 0.2M 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide at 50 ° C. for 5 hours.
The same procedures are repeatedly carried out for the cells 12, 13 and 14, to immobilize second, third and fourth probes, respectively. Finally, all of the cells are washed in an aqueous trimethylammonium solution to remove the byproducts via carbodiimide. There can be produced during the above described procedures a reaction chip having a plurality of independent cells with different immobilized polynucleotide probes on the surfaces thereof.
The method for detecting λ-phage DNA and M13 phage DNA as the target polynucleotides will now be shown below. A fifth probe is a probe for detecting λ-phage DNA and having the 5' terminus labeled with sulforhodamine 101. A sixth probe is a probe for detecting M13 phage and having the 5' terminus labeled with sulforhodamine 101. The method for labeling the 5' termini with sulforhodamine 101 will now be explained in details. The synthesis of each of the probes is done by phosphoramidite method. At the final step of the synthesis, the reaction with N-monomethoxytrityl-aminohexa-6-oxy-β-cyanoethyl-N,N-diisopropylaminophosphoramidite is carried out to introduce the amino group into the 5' termini. After the reaction with 100-fold molar sulforhodamine 101 acid chloride in 0.1 M carbonate buffer (pH 9.0), ethanol precipitation followed by electrophoresis involving 7M urea is done to purify the sulforhodamine 101 labeled probes. Thus, the labeled probes are purified products each of a single band by electrophoresis.
In the reaction chip having a plurality of independent cells with the different polynucleotide probes immobilized on the surface thereof are added a mixture solution of λ-phage DNA and M13 phage DNA and a mixture solution of the labeled probes. The reaction chip is heated at 95° C. for 2 minutes, followed by immediate cooling to 0° C. Subsequently, hybridization reaction is effected at 48° C. Washing is done in a buffer containing 0.1% sodium dodecylsulfate at 25° C. for 30 minutes and further washing is then done at 58° C. in a solution of 0.1% sodium dodecylsulfate, 2 mM EDTA, 3M tetramethylammonium, Tris-HCl, pH 8.0. Subsequently, washing is done in 0.05% polyoxyethylene sorbitan monolaurate, 5 mg/ml bovine serum albumin, 0.15 mol/l NaCl and 0.05 mol/l phosphate buffer, pH 7.4. During the procedure, the target polynucleotides can be captured on the reaction chip and labeled with the labeled probes.
So as to detect the part of the fluorescent dye-labeled probes bonded to the reaction chip after the termination of the reaction, the fluorescence emitted from the reaction chip is measured, using He/Ne laser at 594 nm (or a Na lamp) and a photomultiplier (or a high-sensitivity line sensor and area sensor). Another optical source and fluorophores may satisfactorily be used in combination. Because silicon wafer is used as a chip in the present Example, a reflection-type fluorescence measuring device as shown in FIG. 2 is used. The fluorescence measuring device for practical use according to the present invention will now be explained. The light of laser source 201 expands the beam size through beam expander 202, which is then reflected on dichroic mirror 203. As the dichroic mirror 203, there is used the one which can reflect the light of 594 nm and transmits the light of 610 nm or more at a rate of 80% or more. The light reflected on the dichroic mirror 203 is reflected on mirror 204 which angle can be changed with servo motor 205, and is then reflected again on mirror 206 which angle can be changed into the direction orthogonal to the mirror 204. Subsequently, the light is collimated with a condensing lens 208 to irradiate a specific region on the reaction chip 209. Then, the angle between the mirrors 204 and 206 is modified into the direction orthogonal to each other, so that scanning can be done in the X-Y direction on the reaction chip. When the laser spot directly hits a cell with a fluorophore present, fluorescence is emitted from the portion. Fluorescence progresses through condensing lens 208, mirror 206 and mirror 204 in this order and passes through dichroic mirror 203. After passing through bandpass filter 201, fluorescence is detected with photomultiplier 211. The detected signal is incorporated into microprocessor 212, followed by processing thereof while under the synchronization with the angle information from servo motors 205 and 207, thereby calculating the fluorescence intensity at each cell on the reaction chip surface. By the method, the fluorescence intensity per each cell can be measured.
FIG. 3 depicts the state wherein a target polynucleotide, λ-phage DNA is bonded to the labeled probe. As a second example of the immobilized probe chip, herein, there was employed the one produced by immobilizing the first probe for λ phage and a third probe for M13 phage following the procedure described above. To the cells Nos. 11 and 13 on the surface of chip 49 is bonded probe 50 for λ-phage DNA while probe 51 for M13 phage is bonded to the cells Nos. 12 and 14. The denatured λ phage 52 as a target is bonded to the λ-phage probe on the cells 11 and 13, but is not bonded to the M13 phage probe on the cells 12 and 14. To the λ phage captured on the cells is bonded fluorescent dye-labeled probe 53. FIG. 4 depicts the results of actually measuring a sample containing λ phage alone, a sample containing M13 phage alone and a sample containing the two individually. As is shown in FIG. 4 (1), fluorescence is detected on the cells 11 and 13, with the immobilized λ-phage probe. As is shown in FIG. 4 (2), fluorescence is detected on the cells 12 and 14, with the immobilized M13 phage probe. As is shown in FIG. 4 (3), fluorescence is detected on all of the cells with the immobilized λ-phage probe and with the immobilized M13 phage probe. As has been described above, the presence or absence of a target polynucleotide can be determined on the basis of the portion where fluorescence is detected.
As has been described above, the present invention is used for detecting a plurality of target polynucleotides on a single reaction chip. Thus, the present invention proposes an advantage in that only a single reaction procedure is needed for carrying out a plurality of tests. In case of screening viruses or the like, in particular, subjects for measurement are unknown, generally, so that all potential testing items therefor are preferably tested. The present invention also provides an advantage in that a greater number of items can be measured at a less amount of a sample, compared with conventional tests. This proposes an advantage in that human subjects are exposed to less burdens in collecting body fluids and tissues as measuring subjects.
As is shown in the second example of the chip described above, the immobilization of a single capturing probe onto a plurality of cells and the use thereof can increase detection precision compared with the case when probes are immobilized on a single cell. Furthermore, as is shown in the former part of the present Example described above, the immobilization and use of a plurality of probes onto different cells for a single analytical subject enables the detection of a single polynucleotide using a plurality of different polynucleotide capturing probes, which thus proposes an advantage in that detection precision can be raised compared with the conventional detection method using a probe of a single species. That is, in the first example of the chip of the present Example described above, it is determined as follows; if fluorescence is detected in the first and second cells, λ phage is contained in a sample; if fluorescence is detected only in either cell, a sample may contain λ phage which is suspicious; if no fluorescence is detected in any of the cells, the amount of λ phage in a sample may be quite less. According to the conventional method using a capturing probe of a single species, a contaminating substance similar to a target polynucleotide, if any in a sample, may eventually be detected by mistake, whereas in accordance with the present invention, a plurality of capturing probes immobilized onto different regions are used for detection, giving an advantage in that the influence of such contaminating substance may be decreased.
According to the conventional method, nylon- and nitrocellulose membranes are used as supports, which causes inconvenience for handling because of their less mechanical strength. The present invention is suitable for automatic analysis because chips of silicon and the like are used therein.
Explanation will now follow concerning a method for efficiently effecting the screening of probes for use in DNA diagnostics, employing the present invention.
If the sequence of a target polynucleotide is unknown, the probes for known sequences cannot be used. According to the conventional method, it has been required to determine a part or the whole of the sequence of a target polynucleotide. A method will now be explained, comprising screening probes using the present invention without directly determining the target polynucleotide sequence.
The polynucleotide probes to be used in the present invention individually contain 3' terminal CAT and a 12-bp oligonucleotide composed of a random 3-bp combination of XAA, XGA, XTA, XCA, XAG, XGG, XTG, XCG, XAT, XGT, XTT, XCT, XAC, XGC, XTC, and XCC, and to 5' terminus thereof is bonded an amino group through a spacer. Therefore, the polynucleotide probes to be used in the present Example are in total 4096 types. Herein, X represents the spacer, and as such, there is employed a substance which does not specifically bond individual bases. Following the procedure of Example 1, each probe is immobilized onto each cell on a reaction chip. As sample models, those with Sequence Nos. 10 and 11 are fluorescence labeled by the following method for use. Firstly, a T4 polymerase kinase is used to introduce a phosphate group into the 5' terminus of the sample polynucleotide, according to the method of L. E. Morrison et al. described in Analytical Biochemistry 183, 231-244(1989).
Then, the reaction in a solution, pH 6 containing 0.2M 1-ethyl-3-(dimethylaminopropyl)-carbodiimide and 0.5M ethylenediamine is effected for 18 hours to introduce the amino group into the 5' terminus. After the repetition of ethanol precipitation for removal of unreacted ethylenediamine, there follows the reaction with sulforhodamine 101 acid chloride suspension of a final concentration of 20 mM (60 to 100-fold molar volume of target oligonucleotide) in 0.1M carbonate buffer, pH 9 containing 20% acetonitrile. Removing the unreacted sulforhodamine 101 acid chloride with ethanol precipitation, there is produced a polynucleotide sample with the 5' terminus labeled with sulforhodamine 101. The polynucleotide sample labeled with sulforhodamine 101 reacts with the chip with the 4096 types of probes immobilized onto each cell under hybridization conditions, following Example 1. The non-specifically adsorbed part of the polynucleotide sample is removed with a washing solution at 55° C.
Following Example 1, the fluorescence emitted from each cell of the reaction chip is measured by using He/Ne laser (594 nm) (or Na lamp or the like) and a photomultiplier (or a high-sensitivity line sensor and area sensor). A combination of other light sources and fluorophores may be used satisfactorily. Consequently, it is observed that the polynucleotide sample of Sequence No. 10 is bonded to the cell with the following five types of oligonucleotides immobilized;
5' XTTXTTXGTCAT 3', SEQ ID NO: 1
5' XTAXCAXAGCAT 3', SEQ ID NO: 2
5' XAAXCAXAACAT 3', SEQ ID NO: 3
5' XACXGAXTACAT 3', SEQ ID NO: 4
5' XAGXTTXTGCAT 3', SEQ ID NO: 5
It is observed that the polynucleotide sample of Sequence No. 11 is bonded to the cell with the following two types of oligonucleotides immobilized;
5' XCAXCAXGGCAT 3', SEQ ID NO: 6
5' XTCXGAXACCAT 3', SEQ ID NO: 7
As has been described above, different polynucleotides are to be bonded to different cells on a chip in accordance with the present invention. Because the cell with the immobilized probes to be used in the present invention encompasses all of the possible sequences of a target polynucleotide region starting ATG and having 11 base pairs, it is advantageous that a probe of an oligonucleotide of an unknown sequence can be screened. Because the target polynucleotide region starting ATG may correspond to a DNA open reading frame, furthermore, such probe is useful for screening a polynucleotide fragment possibly containing an open reading frame.
Other examples of the present invention will now be explained hereinbelow.
The polynucleotides to be used in the present Example are as follows:
polynucleotide having a nucleotide sequence, Sequence No. 7; Probe No. 3;
polynucleotide having a nucleotide sequence, Sequence No. 8; Probe No. 4;
polynucleotide having a nucleotide sequence, Sequence No. 9; Probe No. 5.
In the present Example, explanation will follow regarding a method for separating a λ-phage DNA decomposition product as a target polynucleotide sample.
The first to fifth probes are capturing probes recognizing different sites of λ-phage DNA as the target polynucleotide. These are immobilized onto the reaction parts of the reaction chip according to the method of Example 1. As is shown in FIG. 5 depicting the enlarged reaction parts, the cells of the reaction chip to be used herein function also as target polynucleotide separation electrodes 100. Counter electrodes 101 are arranged between the individual cells. FIG. 6 generally depicts the view of the recovery method of target polynucleotide. On substrate 90 are formed target polynucleotide capturing electrodes 111, 113, 115, 117, 119 and counter electrodes 112, 114, 116, 118, 120. In the present Example, the Hind III fragments of λ-phage DNA are added on sample addition part 93 of the support (chip) with five types of immobilized probes for capturing under hybridization conditions. After washing off unreacted substances, the washing solution is then discharged from unreacted solution removing part 94. The procedures thus described are carried out following Example 1. By the procedures, five fragments are captured among the six Hind III fragments. While applying an electric field so as to maintain each cell as positive electrode and the counter electrodes as negative electrodes, a separation solution containing 2.4M tetraethylammonium chloride is added from the sample addition part 93 for heating to 65° C. to 70° C. The separation solution then covers the reaction container in its entirety as shown by 92, and an electric field is applied so as to prepare cells with electrodes for dissociation of hybridized polynucleotides 111, 113, 115, 117, 119 as positive electrodes and counter electrodes 112, 114, 116, 118, 120 as negative electrodes. The target polynucleotides are not eluted at this point because of their negative charge. Then, capillary 131 provided with electrode 132 for capturing eluted target polynucleotides is placed in cell 119, followed by application of an electric field so as to prepare the cell 119 as negative electrode and the electrode 132 in the capillary as positive charge. By the procedure, a first target polynucleotide is recovered and separated. The same procedure is repeated for cells 117, 115, 113, 111 in this order, to recover five types of target polynucleotides. The recovered target polynucleotides are subjected to the analysis with polyacrylamide electrophoresis. It is suggested that the solutions recovered from the cells 119, 117, 115, 113, 111 contain polynucleotides of about 2,000 bp, about 6,600 bp, about 2,300 bp, about 130 bp and about 9,400 bp.
As has been described above, a plurality of target polynucleotides can be separated and recovered readily using the present invention.
As has been described above, also, the present invention enables the simultaneous detection of a plurality of target polynucleotides with a single reaction chip, so it is advantageous to require less reaction procedures compared with the conventional method requiring to prepare one reaction chip per target polynucleotide. Also, the volume of a sample solution should be less because the solution is used for only a single reaction procedure. Furthermore, by detecting a single target polynucleotide with a plurality of probes, the reliability of the measuring results gets higher than the reliability of the conventional methods. According to the present method, a plurality of target polynucleotides can be separated advantageously.
______________________________________Sequence Table______________________________________Sequence No. 1Sequence length:  27Sequence type:    nucleic acidNumber of chains: single strandTopology:         linearSequence species: synthetic polynucleotideSequence:5' CAGAAGAGTT AGTTGACTAT ACAGCCA 3',SEQ ID NO: 8Sequence No. 2Sequence length:  27Sequence type:    nucleic acidNumber of chains: single strandTopology:         linearSequence species: synthetic polynucleotideSequence:5' ATGTTCAGGC AGGGATGTTC TCACCTA 3',SEQ ID NO: 9Sequence No. 3Sequence length:  27Sequence type:    nucleic acidNumber of chains: single strandTopology:         linearSequence species: synthetic polynucleotideSequence:5' ATATAATCCT GATTGTTTGG ATTATAC 3',SEQ ID NO: 10Sequence No. 4Sequence length:  27Sequence type:    nucleic acidNumber of chains: single strandTopology:         linearSequence species: synthetic polynucleotideSequence:5' AAACTAGCAT GTCAATCATA TGTACCC 3',SEQ ID NO: 11Sequence No. 5Sequence length:  40Sequence type:    nucleic acidNumber of chains: single strandTopology:         linearSequence species: synthetic polynucleotideSequence:5' GAGGTGGATA TGGGCCGCAGTGAGGAGAAT AACATCACGC 3',SEQ ID NO: 12Sequence No. 6Sequence length:  40Sequence type:    nucleic acidNumber of chains: single strandTopology:         linearSequence species: synthetic polynucleotideSequence:5' TAAGTATAGC CCGGAATAGG TGTATCACCGTACTCAGGAG 3', SEQ ID NO: 13Sequence No. 7Sequence length:  27Sequence type:    nucleic acidNumber of chains: single strandTopology:         linearSequence species: synthetic polynucleotideSequence:5' CCTACAACCT TAGTAGTTGG TAACCTG 3',SEQ ID NO: 14Sequence No. 8Sequence length:  27Sequence type:    nucleic acidNumber of chains: single strandTopology:         linearSequence species: synthetic polynucleotideSequence:5' ATGACCGCAC CAACAGGCTC CAAGCCA 3',SEQ ID NO: 15Sequence No. 9Sequence length:  27Sequence type:    nucleic acidNumber of chains: single strandTopology:         linearSequence species: synthetic polynucleotideSequence:5' AGCACAAAGC CTCGCAATCC AGTGCAA 3',SEQ ID NO: 16Sequence No. 10Sequence length:  200Sequence type:    nucleic acidNumber of chains: single strandTopology:         linearSequence species: synthetic polynucleotideSequence: ##STR1##Sequence No. 11Sequence length:  201Sequence type:    nucleic acidNumber of chains: single strandTopology:         linearSequence species: synthetic polynucleotideSequence: ##STR2##______________________________________
__________________________________________________________________________SEQUENCE LISTING(1) GENERAL INFORMATION:(iii) NUMBER OF SEQUENCES: 18(2) INFORMATION FOR SEQ ID NO:1:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 9 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:TTTTGTCAT9(2) INFORMATION FOR SEQ ID NO:2:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 9 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:TACAAGCAT9(2) INFORMATION FOR SEQ ID NO:3:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 9 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single (D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:AACAAACAT9(2) INFORMATION FOR SEQ ID NO:4:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 9 base pairs (B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:ACGATACAT9(2) INFORMATION FOR SEQ ID NO:5:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 10 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:AGATTTGCAT 10(2) INFORMATION FOR SEQ ID NO:6:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 9 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:CACAGGCAT 9(2) INFORMATION FOR SEQ ID NO:7:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 9 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:TCGAACCAT 9(2) INFORMATION FOR SEQ ID NO:8:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 27 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:CAGAAGAGTTAGTTGACTATACAGCCA27(2) INFORMATION FOR SEQ ID NO:9:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 27 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:ATGTTCAGGCAGGGATGTTCTCACCTA27(2) INFORMATION FOR SEQ ID NO:10:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 27 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single (D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:ATATAATCCTGATTGTTTGGATTATAC27(2) INFORMATION FOR SEQ ID NO:11:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 27 base pairs( B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:AAACTAGCATGTCAATCATATGTACCC27(2) INFORMATION FOR SEQ ID NO:12:(i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 40 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:GAGGTGGATATGGGCCGCAGTGAGGAGAATAACATCACGC40(2) INFORMATION FOR SEQ ID NO:13:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 40 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:TAAGTATAGCCCGGAATAGGTGTATCACCGTACTCAGGAG 40(2) INFORMATION FOR SEQ ID NO:14:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 27 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:14:CCTACAACCTTAGTAG TTGGTAACCTG27(2) INFORMATION FOR SEQ ID NO:15:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 27 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO( xi) SEQUENCE DESCRIPTION: SEQ ID NO:15:ATGACCGCACCAACAGGCTCCAAGCCA27(2) INFORMATION FOR SEQ ID NO:16:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 27 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:AGCACAAAGCCTCGCAATCCAGTGCAA27(2) INFORMATION FOR SEQ ID NO:17:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 200 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single (D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:17:AGCTTTGCACTGGATTGCGAGGCTTTGTGCTTCTCTGGAGTGCGACAGGTTTGATGACAA60AAAATTAGCGCAAGAAGACAAAAATCACCTTGCGCTAATGCTCTGTTACAGGT CACTAAT120ACCATCTAAGTAGTTGATTCATAGTGACTGCATCTGTTGTGTTTTACAGTATTATGTAGT180CTGTTTTTTATGCAAAATCT200(2) INFORMATION FOR SEQ ID NO:18:(i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 201 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(iii) HYPOTHETICAL: YES(iv) ANTI-SENSE: NO(xi) SEQUENCE DESCRIPTION: SEQ ID NO:18:AATTTAATATATTGATATTTATATCATTTTACGTTTCTCGTTCAGCTTTTTTATACTAAG60TTGGC ATTATAAAAAAGCATTGCTTATCAATTTGTTGCAACGAACAGGTCACTATCAGTC120AAAATAAAATCATTATTTGATTTCAATTTTGTCCCACTCCCTGCCTCTGTCATCACGATA180CTGTGATGCCATGGTGTCCGA 201
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS4859302 *Oct 22, 1987Aug 22, 1989President And Fellows Of Harvard CollegeElectroelution of macromoleculesUS4945045 *Jun 23, 1988Jul 31, 1990Serono Diagnostics Ltd.Electrochemical methods of assayUS5089387 *Jul 7, 1988Feb 18, 1992Adeza Biomedical CorporationDna probe diffraction assay and reagentsWO1988006189A1 *Feb 5, 1988Aug 25, 1988Sdi Diagnostics, Inc.Test system, test device and method for detecting pathogenic organisms and antibiotic resistance genes in body fluids* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS5589330 *Jul 28, 1994Dec 31, 1996Genzyme CorporationHigh-throughput screening method for sequence or genetic alterations in nucleic acids using elution and sequencing of complementary oligonucleotidesUS5605662 *Nov 1, 1993Feb 25, 1997Nanogen, Inc.Active programmable electronic devices for molecular biological analysis and diagnosticsUS5741644 *Jun 5, 1995Apr 21, 1998Hitachi, Ltd.DNA sequencing by extension of probe chip immobilized oligonucleotidesUS5807522 *Jun 7, 1995Sep 15, 1998The Board Of Trustees Of The Leland Stanford Junior UniversityMethods for fabricating microarrays of biological samplesUS5834181 *Sep 13, 1996Nov 10, 1998Genzyme CorporationHigh throughput screening method for sequences or genetic alterations in nucleic acidsUS5849483 *Jun 7, 1995Dec 15, 1998Ig Laboratories, Inc.High throughput screening method for sequences or genetic alterations in nucleic acidsUS5849486 *Sep 27, 1995Dec 15, 1998Nanogen, Inc.Methods for hybridization analysis utilizing electrically controlled hybridizationUS5851772 *Jan 29, 1996Dec 22, 1998University Of ChicagoMicrochip method for the enrichment of specific DNA sequencesUS5929208 *Oct 4, 1996Jul 27, 1999Nanogen, Inc.Methods for electronic synthesis of polymersUS5965452 *Jul 9, 1996Oct 12, 1999Nanogen, Inc.Multiplexed active biologic arrayUS5985555 *Mar 16, 1995Nov 16, 1999Boehringer Mannheim GmbhMethod and apparatus for processing nucleic acids using a small temperature-changing zoneUS6004752 *Oct 23, 1997Dec 21, 1999Sarnoff CorporationSolid support with attached moleculesUS6017696 *Jul 7, 1994Jan 25, 2000Nanogen, Inc.Methods for electronic stringency control for molecular biological analysis and diagnosticsUS6030781 *Oct 23, 1997Feb 29, 2000Motorola, Inc.Electric field amplified oligonucleotide ligase analysisUS6045753 *Oct 23, 1997Apr 4, 2000Sarnoff CorporationDeposited reagents for chemical processesUS6048690 *May 14, 1997Apr 11, 2000Nanogen, Inc.Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesisUS6051380 *Dec 5, 1997Apr 18, 2000Nanogen, Inc.Methods and procedures for molecular biological analysis and diagnosticsUS6068818 *Jan 29, 1999May 30, 2000Nanogen, Inc.Multicomponent devices for molecular biological analysis and diagnosticsUS6071394 *Jan 30, 1998Jun 6, 2000Nanogen, Inc.Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresisUS6110426 *Dec 30, 1997Aug 29, 2000The Board Of Trustees Of The Leland Stanford Junior UniversityMethods for fabricating microarrays of biological samplesUS6129828 *Sep 6, 1996Oct 10, 2000Nanogen, Inc.Apparatus and methods for active biological sample preparationUS6221654 *Sep 23, 1997Apr 24, 2001California Institute Of TechnologyMethod and apparatus for analysis and sorting of polynucleotides based on sizeUS6225059Jan 29, 1999May 1, 2001Nanogen, Inc.Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnosticsUS6238624Oct 4, 1996May 29, 2001Nanogen, Inc.Methods for transport in molecular biological analysis and diagnosticsUS6245508Aug 27, 1998Jun 12, 2001Nanogen, Inc.Method for fingerprinting utilizing an electronically addressable arrayUS6254827Jan 29, 1999Jul 3, 2001Nanogen, Inc.Methods for fabricating multi-component devices for molecular biological analysis and diagnosticsUS6258606Jul 30, 1999Jul 10, 2001Nanogen, Inc.Multiplexed active biologic arrayUS6280590Apr 13, 2000Aug 28, 2001Nanogen, Inc.Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresisUS6287517Dec 4, 1996Sep 11, 2001Nanogen, Inc.Laminated assembly for active bioelectronic devicesUS6309602Dec 2, 1998Oct 30, 2001Nanogen, Inc.Stacked, reconfigurable system for electrophoretic transport of charged materialsUS6315953Jan 29, 1999Nov 13, 2001Nanogen, Inc.Devices for molecular biological analysis and diagnostics including waveguidesUS6319472Dec 2, 1998Nov 20, 2001Nanogen, Inc.System including functionally separated regions in electrophoretic systemUS6331274Jan 29, 1999Dec 18, 2001Nanogen, Inc.Advanced active circuits and devices for molecular biological analysis and diagnosticsUS6344316Jun 25, 1997Feb 5, 2002Affymetrix, Inc.Nucleic acid analysis techniquesUS6368674Jun 24, 1999Apr 9, 2002Sarnoff CorporationMethod of fabricating a support with dry deposited compounds thereonUS6375899Dec 2, 1998Apr 23, 2002Nanogen, Inc.Electrophoretic buss for transport of charged materials in a multi-chamber systemUS6398932May 26, 2000Jun 4, 2002Large Scale Proteomics Corp.Automated system for two-dimensional electrophoresisUS6403367Dec 22, 1999Jun 11, 2002Nanogen, Inc.Integrated portable biological detection systemUS6410229Dec 14, 1998Jun 25, 2002Affymetrix, Inc.Expression monitoring by hybridization to high density nucleic acid arraysUS6416644Oct 6, 2000Jul 9, 2002Large Scale Proteomics Corp.Automated system for two-dimensional electrophoresisUS6423271Mar 16, 2000Jul 23, 2002Nanogen, Inc.Laminated assembly for active bioelectronic devicesUS6438259Aug 17, 2000Aug 20, 2002Large Scale Biology CorporationComputer-assisted methods and apparatus for identification and characterization of biomoleculesUS6479644 *Jun 28, 1997Nov 12, 2002Wolf BertlingMethod for purifying and enriching moleculesUS6482303Mar 21, 2001Nov 19, 2002Large Scale Proteomics Corp.Automated system for two-dimensional electrophoresisUS6507664Aug 17, 2000Jan 14, 2003Large Scale Biology CorporationTwo-dimensional gels for separation, identification and characterization of biomoleculesUS6518022Nov 22, 1999Feb 11, 2003Nanogen, Inc.Method for enhancing the hybridization efficiency of target nucleic acids using a self-addressable, self-assembling microelectronic deviceUS6518056Apr 27, 1999Feb 11, 2003Agilent Technologies Inc.Apparatus, systems and method for assaying biological materials using an annular formatUS6539102Sep 1, 2000Mar 25, 2003Large Scale ProteomicsReference databaseUS6540961Mar 21, 2000Apr 1, 2003Nanogen, Inc.Multicomponent devices for molecular biological analysis and diagnosticsUS6548257Aug 22, 2001Apr 15, 2003Affymetrix, Inc.Methods of identifying nucleic acid probes to quantify the expression of a target nucleic acidUS6554991Sep 21, 2000Apr 29, 2003Large Scale Proteomics CorporationAutomated system for two-dimensional electrophoresisUS6569382Nov 8, 1999May 27, 2003Nanogen, Inc.Methods apparatus for the electronic, homogeneous assembly and fabrication of devicesUS6582660May 20, 1997Jun 24, 2003Nanogen, Inc.Control system for active programmable electronic microbiology systemUS6638482Dec 2, 1998Oct 28, 2003Nanogen, Inc.Reconfigurable detection and analysis apparatus and methodUS6643391Apr 4, 2002Nov 4, 2003Large Scale Proteomics CorporationApparatus for computer-assisted isolation and characterization of proteinsUS6652808Dec 6, 1996Nov 25, 2003Nanotronics, Inc.Methods for the electronic assembly and fabrication of devicesUS6682936Jul 10, 2001Jan 27, 2004Nanogen, Inc.Addressable biologic electrode arrayUS6706473Jan 24, 2000Mar 16, 2004Nanogen, Inc.Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotidesUS6726880Jun 19, 2000Apr 27, 2004Nanogen, Inc.Electronic device for performing active biological operations and method of using sameUS6821729Sep 12, 2001Nov 23, 2004Nanogen, Inc.Devices for molecular biological analysis and diagnostics including waveguidesUS6824740Apr 28, 2000Nov 30, 2004Nanogen, Inc.Apparatus for active biological sample preparationUS6867048May 7, 2002Mar 15, 2005Nanogen, Inc.Multiplexed active biologic arrayUS6887362Feb 6, 2002May 3, 2005Nanogen, Inc.Dielectrophoretic separation and immunoassay methods on active electronic matrix devicesUS6927032Jan 28, 2003Aug 9, 2005Affymetrix, Inc.Expression monitoring by hybridization to high density oligonucleotide arraysUS6980674Jan 4, 2001Dec 27, 2005Large Scale Proteomics Corp.Reference databaseUS6989086Jul 13, 2001Jan 24, 2006Nanogen, Inc.Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresisUS7045097May 7, 2002May 16, 2006Nanogen, Inc.Biologic electrode array with integrated optical detectorUS7060224Jan 6, 2003Jun 13, 2006Nanogen, Inc.Methods for the electronic, homogeneous assembly and fabrication of devicesUS7101661Jun 20, 2000Sep 5, 2006Nanogen, Inc.Apparatus for active programmable matrix devicesUS7101717Jan 23, 2004Sep 5, 2006Nanogen, Inc.Addressable biologic electrode arrayUS7118910Nov 27, 2002Oct 10, 2006Fluidigm CorporationMicrofluidic device and methods of using sameUS7130459Nov 18, 2002Oct 31, 2006Large Scale Biology CorporationReference databaseUS7133544Feb 9, 2005Nov 7, 2006Large Scale Biology CorporationReference databaseUS7150997Mar 15, 2005Dec 19, 2006Nanogen, Inc.Multiplexed active biologic arrayUS7153955May 16, 2002Dec 26, 2006Nanogen Recognomics GmbhPentopyranosyl nucleic acid arrays, and uses thereofUS7172864Jan 24, 2000Feb 6, 2007NanogenMethods for electronically-controlled enzymatic reactionsUS7172896Jun 5, 2002Feb 6, 2007Nanogen, Inc.Integrated portable biological detection systemUS7214298Aug 13, 2001May 8, 2007California Institute Of TechnologyMicrofabricated cell sorterUS7267751Aug 20, 2002Sep 11, 2007Nanogen, Inc.Programmable multiplexed active biologic arrayUS7312085Apr 1, 2003Dec 25, 2007Fluidigm CorporationMicrofluidic particle-analysis systemsUS7314542Sep 22, 2005Jan 1, 2008Nanogen, Inc.Methods and materials for optimization of electronic transportation and hybridization reactionsUS7314708Aug 4, 1998Jan 1, 2008Nanogen, Inc.Method and apparatus for electronic synthesis of molecular structuresUS7323298Jul 30, 1996Jan 29, 2008The Board Of Trustees Of The Leland Stanford Junior UniversityMicroarray for determining the relative abundances of polynuceotide sequencesUS7335470Oct 15, 2002Feb 26, 2008Perkinelmer, Las, Inc.Compilations of nucleic acids and arrays and methods of using themUS7351376Nov 28, 2000Apr 1, 2008California Institute Of TechnologyIntegrated active flux microfluidic devices and methodsUS7378236Aug 14, 1995May 27, 2008The Board Of Trustees Of The Leland Stanford Junior UniversityMethod for analyzing gene expression patternsUS7381525 *Jun 12, 1997Jun 3, 2008Clinical Micro Sensors, Inc.AC/DC voltage apparatus for detection of nucleic acidsUS7408049Jul 19, 2004Aug 5, 2008Invitrogen CorporationRecombinational cloning using nucleic acids having recombination sitesUS7425308May 4, 2001Sep 16, 2008Nanogen, Inc.Systems for the active electronic control of biological reactionsUS7439346May 17, 2004Oct 21, 2008Perkinelmer Las Inc.Nucleic acids arrays and methods of use thereforUS7452726Dec 11, 2003Nov 18, 2008Fluidigm CorporationMicrofluidic particle-analysis systemsUS7498342Jun 16, 2005Mar 3, 2009Plexxikon, Inc.Compounds modulating c-kit activityUS7504509Dec 17, 2004Mar 17, 2009Plexxikon, Inc.Compounds and methods for development of Ret modulatorsUS7507539Jul 30, 2007Mar 24, 2009Quest Diagnostics Investments IncorporatedSubstractive single label comparative hybridizationUS7582421Sep 16, 2002Sep 1, 2009Nanogen, Inc.Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchipUS7585859May 6, 2005Sep 8, 2009Plexxikon, Inc.PDE4B inhibitors and uses thereforUS7601301Dec 15, 2006Oct 13, 2009Nanogen, Inc.Multiplexed active biologic arrayUS7601493Jul 24, 2003Oct 13, 2009Nanogen, Inc.Methods and apparatus for screening and detecting multiple genetic mutationsUS7604965Mar 18, 2005Oct 20, 2009Fluidigm CorporationThermal reaction device and method for using the sameUS7605168Sep 2, 2005Oct 20, 2009Plexxikon, Inc.PDE4B inhibitorsUS7622081Mar 15, 2004Nov 24, 2009California Institute Of TechnologyIntegrated active flux microfluidic devices and methodsUS7670471Oct 21, 2005Mar 2, 2010California Institute Of TechnologyMethod and apparatus for analysis and sorting of polynucleotides based on sizeUS7691333Apr 5, 2004Apr 6, 2010Fluidigm CorporationMicrofluidic device and methods of using sameUS7704726Aug 17, 2006Apr 27, 2010Gamida For Life B.V.Active programmable matrix devicesUS7749737Oct 30, 2007Jul 6, 2010Fluidigm CorporationThermal reaction device and method for using the sameUS7820427Sep 12, 2006Oct 26, 2010Fluidigm CorporationMicrofluidic device and methods of using sameUS7828954Sep 21, 2005Nov 9, 2010Gamida For Life B.V.Electrode based patterning of thin film self-assembled nanoparticlesUS7833708May 19, 2005Nov 16, 2010California Institute Of TechnologyNucleic acid amplification using microfluidic devicesUS7837946Nov 6, 2008Nov 23, 2010Fluidigm CorporationMicrofluidic device and methods of using sameUS7846941May 16, 2006Dec 7, 2010Plexxikon, Inc.Compounds modulating c-kit and c-fms activity and uses thereforUS7857957Feb 5, 2007Dec 28, 2010Gamida For Life B.V.Integrated portable biological detection systemUS7858034Jul 10, 2007Dec 28, 2010Gamida For Life B.V.Circuits for the control of output current in an electronic device for performing active biological operationsUS7863288Jun 21, 2006Jan 4, 2011Plexxikon, Inc.Compounds and methods for kinase modulation, and indications thereforUS7863289Dec 19, 2007Jan 4, 2011Plexxikon, Inc.Compounds and methods for kinase modulation, and indications thereforUS7867454Oct 30, 2007Jan 11, 2011Fluidigm CorporationThermal reaction device and method for using the sameUS7872018Dec 20, 2007Jan 18, 2011Plexxikon, Inc.Compounds and methods for kinase modulation, and indications thereforUS7892743Feb 25, 2009Feb 22, 2011Quest Diagnostics Investments IncorporatedSubtractive single label comparative hybridizationUS7893075Nov 21, 2007Feb 22, 2011Plexxikon, Inc.Compounds modulating c-fms and/or c-kit activity and uses thereforUS7947486Feb 5, 2007May 24, 2011Gamida For Life B.V.Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnosticsUS7947708Oct 2, 2008May 24, 2011Plexxikon, Inc.Compounds modulating C-kit activityUS8007746Oct 30, 2007Aug 30, 2011Fluidigm CorporationMicrofluidic devices and methods of using sameUS8021888Jan 26, 2006Sep 20, 2011Quest Diagnostics Investments IncorporatedRapid comparative genomic hybridization using acoustic surface wavesUS8030066Dec 18, 2006Oct 4, 2011Life Technologies CorporationMethods and compositions for synthesis of nucleic acid molecules using multiple recognition sitesUS8067434Apr 11, 2008Nov 29, 2011Plexxikon Inc.Compounds and methods for development of Ret modulatorsUS8076074Nov 29, 2005Dec 13, 2011Quest Diagnostics Investments IncorporatedBalanced translocation in comparative hybridizationUS8114589Mar 22, 2007Feb 14, 2012Gamida For Life B.V.Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnosticsUS8129176Aug 5, 2009Mar 6, 2012California Institute Of TechnologyIntegrated active flux microfluidic devices and methodsUS8153391Aug 29, 2008Apr 10, 2012Bunge Oils, Inc.Hydrolases, nucleic acids encoding them and methods for making and using themUS8163492Aug 17, 2010Apr 24, 2012Fluidign CorporationMicrofluidic device and methods of using sameUS8173001Jan 11, 2010May 8, 2012California Institute Of TechnologyMethod and apparatus for analysis and sorting of polynucleotides based on sizeUS8227215Apr 8, 2011Jul 24, 2012Bunge Oils, Inc.Hydrolases, nucleic acids encoding them and methods for making and using them for biocatalytic synthesis of a structured lipidUS8247178Oct 14, 2009Aug 21, 2012Fluidigm CorporationThermal reaction device and method for using the sameUS8257666Feb 8, 2012Sep 4, 2012California Institute Of TechnologyIntegrated active flux microfluidic devices and methodsUS8268858Dec 20, 2007Sep 18, 2012Plexxikon Inc.Compounds and methods for kinase modulation, and indications thereforUS8304189Dec 1, 2004Nov 6, 2012Life Technologies CorporationNucleic acid molecules containing recombination sites and methods of using the sameUS8313918Apr 8, 2011Nov 20, 2012Bunge Oils, Inc.Hydrolases, nucleic acids encoding them and methods to produce triglyceridesUS8313940Dec 21, 2007Nov 20, 2012Gamida For Life B.V.Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnosticsUS8343442Aug 18, 2010Jan 1, 2013Fluidigm CorporationMicrofluidic device and methods of using sameUS8349578Apr 8, 2011Jan 8, 2013Bunge Oils, Inc.Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipidsUS8357503Aug 28, 2009Jan 22, 2013Bunge Oils, Inc.Hydrolases, nucleic acids encoding them and methods for making and using themUS8388822Mar 22, 2012Mar 5, 2013California Institute Of TechnologyMethod and apparatus for analysis and sorting of polynucleotides based on sizeUS8389212Jul 22, 1999Mar 5, 2013Gamida For Life, B.V.Method for the electronic analysis of a sample oligonucleotide sequenceUS8404700Jul 11, 2012Mar 26, 2013Plexxikon Inc.Compounds modulating c-fms and/or c-kit activity and uses thereforUS8415469Nov 10, 2009Apr 9, 2013Plexxikon Inc.Compounds and methods for kinase modulation, and indications thereforUS8420342Apr 8, 2011Apr 16, 2013Bunge Oils, Inc.Hydrolases, nucleic acids encoding them and methods to produce triglyceridesUS8461169Dec 1, 2010Jun 11, 2013Plexxikon Inc.Compounds modulating c-fms and/or c-kit activityUS8465942Jun 19, 2012Jun 18, 2013Bunge Oils, Inc.Hydrolases, nucleic acids encoding them and methods for making and using themUS8470818Oct 18, 2010Jun 25, 2013Plexxikon Inc.Compounds and methods for kinase modulation, and indications thereforUS8470821Jul 20, 2009Jun 25, 2013Plexxikon Inc.PDE4B inhibitors and uses thereforUS8486636Nov 16, 2010Jul 16, 2013California Institute Of TechnologyNucleic acid amplification using microfluidic devicesUS8492089Feb 16, 2011Jul 23, 2013Quest Diagnostics Investments IncorporatedSubtractive single label comparative hybridizationUS8541191Apr 8, 2011Sep 24, 2013Bunge Oils, Inc.Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipidsUS8618248Oct 30, 2007Dec 31, 2013President And Fellows Of Harvard CollegePhosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptidesUS8658418Jul 13, 2009Feb 25, 2014Fluidigm CorporationMicrofluidic particle-analysis systemsUS8722702Feb 25, 2013May 13, 2014Plexxikon Inc.Compounds modulating c-fms and/or c-kit activity and uses thereforUS8741920Sep 13, 2012Jun 3, 2014Hoffmann-La Roche, Inc.Process for the manufacture of pharmaceutically active compoundsUS8772467Oct 7, 2009Jul 8, 2014Gamida For Life B.V.Methods and apparatus for screening and detecting multiple genetic mutationsUS8828663Mar 20, 2006Sep 9, 2014Fluidigm CorporationThermal reaction device and method for using the sameUS8865735Feb 21, 2012Oct 21, 2014Hoffman-La Roche Inc.Solid forms of a pharmaceutically active substanceUS8871446Oct 2, 2003Oct 28, 2014California Institute Of TechnologyMicrofluidic nucleic acid analysisUS8911942May 19, 2005Dec 16, 2014Quest Diagnostics Investments IncorporatedSingle label comparative hybridizationUS8936764Jul 2, 2013Jan 20, 2015California Institute Of TechnologyNucleic acid amplification using microfluidic devicesUS8945884May 13, 2013Feb 3, 2015Life Technologies CorporationMethods and compositions for synthesis of nucleic acid molecules using multiplerecognition sitesUS9045712Oct 8, 2010Jun 2, 2015Bunge Global Innovation, LlcOil degumming methodsUS9096593Sep 20, 2013Aug 4, 2015Plexxikon Inc.Compounds and methods for kinase modulation, and indications thereforUS9150570Mar 11, 2013Oct 6, 2015Plexxikon Inc.Synthesis of heterocyclic compoundsUS9150913Jul 12, 2012Oct 6, 2015Fluidigm CorporationThermal reaction device and method for using the sameUS9169250Apr 10, 2014Oct 27, 2015Plexxikon Inc.Compounds modulating c-fms and/or c-kit activity and uses thereforUS9267171Feb 28, 2014Feb 23, 2016New York UniversityDNA photolithography with cinnamate crosslinkersUS9309520Dec 19, 2014Apr 12, 2016Life Technologies CorporationMethods and compositions for synthesis of nucleic acid molecules using multiple recognition sitesUS9383337Jan 14, 2013Jul 5, 2016California Institute Of TechnologyMethod and apparatus for analysis and sorting of polynucleotides based on sizeUS9447089Mar 31, 2010Sep 20, 2016Plexxikon Inc.Compositions and uses thereofUS9469640Feb 19, 2016Oct 18, 2016Plexxikon Inc.Compounds and methods for kinase modulation, and indications thereforUS9487515Jun 8, 2015Nov 8, 2016Plexxikon Inc.Compounds modulating c-fms and/or c-kit activity and uses thereforUS9512382Aug 19, 2014Dec 6, 2016Bunge Global Innovation, LlcOil degumming methodsUS9534252Sep 14, 2012Jan 3, 2017Life Technologies CorporationNucleic acid molecules containing recombination sites and methods of using the sameUS9579650Sep 23, 2014Feb 28, 2017California Institute Of TechnologyMicrofluidic nucleic acid analysisUS9624213Feb 1, 2012Apr 18, 2017Plexxikon Inc.Compounds and methods for kinase modulation, and indications thereforUS20010045359 *Jul 13, 2001Nov 29, 2001Nanogen, Inc.Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresisUS20020005354 *Aug 13, 2001Jan 17, 2002California Institute Of TechnologyMicrofabricated cell sorterUS20020012926 *Mar 5, 2001Jan 31, 2002Mycometrix, Inc.Combinatorial array for nucleic acid analysisUS20020028005 *Jan 4, 2001Mar 7, 2002Anderson Norman G.Reference databaseUS20020028503 *Sep 12, 2001Mar 7, 2002Nanogen, Inc.Devices for molecular biological analysis and diagnostics including waveguidesUS20020119484 *Feb 12, 2002Aug 29, 2002Nanogen, Inc.Primer extension detection methods on active electronic microarraysUS20020127733 *May 7, 2002Sep 12, 2002Nanogen, Inc.Multiplexed active biologic arrayUS20020131899 *May 7, 2002Sep 19, 2002Nanogen, Inc.Biologic electrode array with integrated optical detectorUS20020150887 *Nov 9, 2001Oct 17, 2002National Institute Of Advanced Industrial Science And TechnologyMethods and nucleic acid probes for molecular genetic analysis of polluted environments and environmental samplesUS20020155586 *Jun 5, 2002Oct 24, 2002Nanogen, Inc.Integrated portable biological detection systemUS20020157954 *Mar 13, 2002Oct 31, 2002Anderson N. LeighAutomated system for two-dimensional electrophoresisUS20030009293 *Sep 6, 2002Jan 9, 2003Anderson Norman G.Reference databaseUS20030012695 *Nov 24, 1998Jan 16, 2003Tidhar Dari ShalonSubstrates comprising polynucleotide microarraysUS20030036077 *May 31, 2002Feb 20, 2003Chronix BiomedicalMethods for generating an mRNA expression profile from an ecellular mRNA containing blood sample and using the same to identify functional state markersUS20030039997 *May 16, 2002Feb 27, 2003Aventis Research And Technologies Gmbh & Co. KgPentopyranosyl nucleic acid arrays, and uses thereofUS20030059095 *Nov 18, 2002Mar 27, 2003Anderson Norman G.Reference databaseUS20030059929 *Jul 24, 2001Mar 27, 2003Nanogen, Inc.Methods for electronic synthesis of complex structuresUS20030073122 *Sep 16, 2002Apr 17, 2003Nanogen, Inc.Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchipUS20030138829 *Nov 27, 2002Jul 24, 2003Fluidigm Corp.Microfluidic device and methods of using sameUS20030146095 *Jan 6, 2003Aug 7, 2003Nanogen, Inc.Methods for the electronic, Homogeneous assembly and fabrication of devicesUS20030146100 *Feb 6, 2002Aug 7, 2003Nanogen, Inc.Dielectrophoretic separation and immunoassay methods on active electronic matrix devicesUS20030190632 *Jun 11, 2002Oct 9, 2003Nanogen, Inc.Method for enhancing the hybridization efficiency of target nucleic acids using a self-addressable, self-assembling microelectronic deviceUS20040002085 *Feb 5, 2003Jan 1, 2004Schembri Carol T.Apparatus, systems and method for assaying biological materials using an annular formatUS20040038420 *Aug 20, 2002Feb 26, 2004Nanogen, Inc.Programmable multiplexed active biologic arrayUS20040072278 *Apr 1, 2003Apr 15, 2004Fluidigm CorporationMicrofluidic particle-analysis systemsUS20040077074 *Oct 14, 2003Apr 22, 2004Nanogen, Inc.Multi-chambered analysis deviceUS20040086917 *Jul 18, 2003May 6, 2004Nanogen, Inc.Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesisUS20040115696 *Jul 31, 2003Jun 17, 2004Nanotronics, Inc.Affinity based self-assembly systems and devices for photonic and electronic applicationsUS20040142864 *Sep 16, 2003Jul 22, 2004Plexxikon, Inc.Crystal structure of PIM-1 kinaseUS20040146880 *Jul 24, 2003Jul 29, 2004Nanogen, Inc.Methods and apparatus for screening and detecting multiple genetic mutationsUS20040149582 *Jan 23, 2004Aug 5, 2004Nanogen, Inc.Addressable biologic electrode arrayUS20040248167 *Mar 15, 2004Dec 9, 2004Quake Stephen R.Integrated active flux microfluidic devices and methodsUS20040253631 *Jul 19, 2004Dec 16, 2004Invitrogen CorporationRecombinational cloning using nucleic acids having recombination sitesUS20050009091 *Aug 19, 2004Jan 13, 2005Invitrogen CorporationRecombinational cloning using nucleic acids having recombination sitesUS20050032060 *Aug 30, 2002Feb 10, 2005Shishir ShahArrays comprising pre-labeled biological molecules and methods for making and using these arraysUS20050048573 *Feb 3, 2004Mar 3, 2005Plexxikon, Inc.PDE5A crystal structure and usesUS20050059041 *May 17, 2004Mar 17, 2005Johnson Robert C.Nucleic acids arrays and methods of use thereforUS20050079548 *Jul 7, 2004Apr 14, 2005Plexxikon, Inc.Ligand development using PDE4B crystal structuresUS20050123947 *Aug 13, 2004Jun 9, 2005California Institute Of TechnologyMethods and systems for molecular fingerprintingUS20050126911 *Jan 31, 2005Jun 16, 2005Large Scale Biology CorporationAutomated system for two-dimensional electrophoresisUS20050145496 *Jun 23, 2004Jul 7, 2005Federico GoodsaidThermal reaction device and method for using the sameUS20050147984 *Feb 27, 2004Jul 7, 2005Clondiag Chip Technologies GmbhInteraction detection on several probe arraysUS20050155863 *Mar 15, 2005Jul 21, 2005NanogenMultiplexed active biologic arrayUS20050158746 *Nov 23, 2004Jul 21, 2005Affymetrix Inc.Expression monitoring by hybridization to high density oligonucleotide arraysUS20050164300 *Sep 15, 2004Jul 28, 2005Plexxikon, Inc.Molecular scaffolds for kinase ligand developmentUS20050170431 *Feb 27, 2004Aug 4, 2005Plexxikon, Inc.PYK2 crystal structure and usesUS20050170432 *Feb 9, 2005Aug 4, 2005Large Scale Proteomics Corporation, A Division Of Large Scale Biology CorporationReference databaseUS20050196785 *Jan 5, 2005Sep 8, 2005California Institute Of TechnologyCombinational array for nucleic acid analysisUS20050202500 *Apr 28, 2005Sep 15, 2005Affymetrix, Inc.Expression monitoring to high density oligonucleotide arraysUS20050260665 *May 19, 2005Nov 24, 2005Quest Diagnostics Investments IncorporatedSingle label comparative hybridizationUS20050266568 *Apr 8, 2005Dec 1, 2005Fujitsu LimitedMolecule-releasing apparatus and molecule-releasing medhodUS20060003437 *Sep 13, 2005Jan 5, 2006Fujitsu LimitedTarget detecting device and target capturer, device and method for molecular adsorption or desorption, and device and method for protein detectionUS20060041006 *May 6, 2005Feb 23, 2006Ibrahim Prabha NPDE4B inhibitors and uses thereforUS20060058339 *Jun 16, 2005Mar 16, 2006Ibrahim Prabha NCompounds modulating c-kit activity and uses thereforUS20060065531 *Sep 22, 2005Mar 30, 2006Nanogen, IncMethods and materials for optimization of electronic transportation and hybridization reactionsUS20060100218 *Sep 2, 2005May 11, 2006Ibrahim Prabha NPDE4B inhibitorsUS20070004031 *Sep 12, 2006Jan 4, 2007Fluidigm CorporationMicrofluidic device and methods of using sameUS20070032519 *May 16, 2006Feb 8, 2007Chao ZhangCompounds modulating c-kit and c-fms activity and uses thereforUS20070066641 *Jul 14, 2006Mar 22, 2007Prabha IbrahimCompounds and methods for development of RET modulatorsUS20070095671 *Dec 15, 2006May 3, 2007Nanogen, Inc.Multiplexed active biologic arrayUS20070138024 *Sep 21, 2005Jun 21, 2007Swanson Paul DElectrode based patterning of thin film self-assembled nanoparticlesUS20070178516 *Mar 22, 2007Aug 2, 2007Nanogen, Inc.Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnosticsUS20070212689 *Oct 29, 2004Sep 13, 2007Bianchi Diana WPrenatal Diagnosis Using Cell-Free Fetal DNA in Amniotic FluidUS20070232556 *Mar 31, 2006Oct 4, 2007Montine Thomas JMethods and compositions for the treatment of neurological diseases and disordersUS20080047832 *Feb 5, 2007Feb 28, 2008NanogenIntegrated portable biological detection systemUS20080167338 *Dec 19, 2007Jul 10, 2008Wayne SpevakCompounds and methods for kinase modulation, and indications thereforUS20080188514 *Dec 20, 2007Aug 7, 2008Guoxian WuCompounds and methods for kinase modulation, and indications thereforUS20080203502 *Dec 21, 2007Aug 28, 2008Heller Michael JSelf-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnosticsUS20080274904 *Aug 9, 2007Nov 6, 2008Niall Anthony GormleyMethod of target enrichmentUS20090035757 *Jul 30, 2007Feb 5, 2009Quest Diagnostics Investments IncorporatedSubstractive single label comparative hybridizationUS20090076046 *Nov 21, 2007Mar 19, 2009Plexxikon IncCompounds modulating c-fms and/or c-kit activity and uses thereforUS20090105297 *Oct 2, 2008Apr 23, 2009Plexxikon IncCompounds Modulating C-Kit ActivityUS20090155809 *Feb 25, 2009Jun 18, 2009Renius OwenSubtractive single label comparative hybridizationUS20100120018 *Aug 5, 2009May 13, 2010California Institute Of TechnologyIntegrated Active Flux Microfluidic Devices and MethodsUS20100167960 *Oct 7, 2009Jul 1, 2010Radtkey Ray RMethods and apparatus for screening and detecting multiple genetic mutationsUS20100171954 *Jan 11, 2010Jul 8, 2010California Institute Of TechnologyMethod and Apparatus for Analysis and Sorting of Polynucleotides Based on SizeUS20100249118 *Jun 21, 2006Sep 30, 2010Ibrahim Prabha NCompounds and methods for kinase modulation, and indications thereforUS20100256365 *Nov 10, 2009Oct 7, 2010Plexxikon, Inc.Compounds and methods for kinase modulation, and indications thereforUS20100260739 *Mar 9, 2010Oct 14, 2010Bioatla, LlcMirac ProteinsUS20100310659 *Mar 31, 2010Dec 9, 2010Plexxikon, Inc.Compositions and Uses ThereofUS20100324065 *Apr 11, 2008Dec 23, 2010Plexxikon IncCompounds and methods for development of Ret ModulatorsUS20110059963 *Oct 18, 2010Mar 10, 2011Plexxikon, Inc.Compounds and methods for kinase modulation, and indications thereforUS20110086772 *Sep 27, 2010Apr 14, 2011Signature Genomics Laboratories LlcMultiplex (+/-) stranded arrays and assays for detecting chromosomal abnormalities associated with cancer and other diseasesUS20110092538 *Dec 29, 2010Apr 21, 2011Plexxikon Inc.Compounds and methods for kinase modulation, and indications thereforUS20110118125 *May 1, 2009May 19, 2011Tufts Medical Center, Inc.Neonatal salivary genomicsUS20110143957 *Feb 16, 2011Jun 16, 2011Quest Diagnostics Investments IncorporatedSubtractive single label comparative hybridizationUS20110166174 *Dec 1, 2010Jul 7, 2011Plexxikon, Inc.Compounds modulating c-kit and c-fms activity and uses thereforUS20110229872 *Nov 24, 2010Sep 22, 2011California Institute Of TechnologyMicrofabricated Cell SorterEP1588755A1 *Nov 26, 2003Oct 26, 2005Fujitsu LimitedTarget detecting device and target capturer, molecule adsorption/desorption device and molecule adsoprtion/desoption method, and protein detecting device and protein detecting methodEP1588755A4 *Nov 26, 2003May 30, 2007Fujitsu LtdTarget detecting device and target capturer, molecule adsorption/desorption device and molecule adsoprtion/desoption method, and protein detecting device and protein detecting methodEP2112227A1Mar 7, 2007Oct 28, 2009Cargill, IncorporatedAldolases, nucleic acids encoding them and methods for making and using themEP2194133A2Mar 8, 2004Jun 9, 2010Verenium CorporationAmylases, nucleic acids encoding them and methods for making and using themEP2216403A2Feb 2, 2007Aug 11, 2010Verenium CorporationEsterases and related nucleic acids and methodsEP2298871A1Apr 21, 2003Mar 23, 2011Verenium CorporationPhospholipases, nucleic acids encoding them and methods for making and using themEP2316962A1Mar 7, 2007May 4, 2011Cargill, IncorporatedAldolases, nucleic acids encoding them and methods for making and using themEP2322643A1Mar 7, 2007May 18, 2011Cargill, IncorporatedAldolases, nucleic acids encoding them and methods for making and using themEP2341136A1Apr 2, 2004Jul 6, 2011Verenium CorporationPectate lyases, Nucleic Acids encoding them and methods for making and using themEP2385108A1Mar 7, 2007Nov 9, 2011Verenium CorporationAldolases, nucleic acids encoding them and methods for making and using themEP2388316A2Mar 7, 2007Nov 23, 2011Verenium CorporationAldolases, nucleic acids encoding them and methods for making and using themEP2397486A1Sep 21, 2007Dec 21, 2011Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themEP2404928A1Jul 2, 2004Jan 11, 2012Verenium CorporationGlucanases, nucleic acids encoding them and methods for making and using themEP2404929A1Jul 2, 2004Jan 11, 2012Verenium CorporationGlucanases, nucleic acids encoding them and methods for making and using themEP2404930A1Jul 2, 2004Jan 11, 2012Verenium CorporationGlucanases, nucleic acids encoding them and methods for making and using themEP2404931A1Jul 2, 2004Jan 11, 2012Verenium CorporationGlucanases, nucleic acids encoding them and methods for making and using themEP2409981A1Jul 2, 2004Jan 25, 2012Verenium CorporationGlucanases, nucleic acids encoding them and methods for making and using themEP2415864A1Dec 8, 2006Feb 8, 2012Verenium CorporationOligomerase-2 (or beta-xylosidase) enzymes, nucleic acids encoding them and methods for making and using themEP2420570A1Dec 8, 2006Feb 22, 2012Verenium CorporationArabinofuranosidase enzymes, nucleic acids encoding them and methods for making and using themEP2444413A1Aug 4, 2007Apr 25, 2012Verenium CorporationMethods for oil or gas well drilling, washing and/or fracturingEP2444487A1Dec 8, 2006Apr 25, 2012Verenium CorporationCellulolytic enzymes, nucleic acids encoding them and methods for making and using themEP2444488A1Dec 8, 2006Apr 25, 2012Verenium CorporationCellucloytic enzymes, nucleic acids encoding them and methods for making and using themEP2444489A1Dec 8, 2006Apr 25, 2012Verenium CorporationCellucloytic enzymes, nucleic acids encoding them and methods for making and using themEP2444490A1Dec 8, 2006Apr 25, 2012Verenium CorporationCellulolytic enzymes, nucleic acids encoding them and methods for making and using themEP2447363A1Dec 8, 2006May 2, 2012Verenium CorporationCellucloytic enzymes, nucleic acids encoding them and methods for making and using themEP2450439A1Dec 8, 2006May 9, 2012Verenium CorporationCellulolytic enzymes, nucleic acids encoding them and methods for making and using themEP2468853A1Jun 14, 2005Jun 27, 2012Verenium CorporationComposition and methods for enzymatic decolorization of chlorophyllEP2479266A1Dec 21, 2007Jul 25, 2012Verenium CorporationAmylases and glucoamylases, nucleic acids encoding them and methods for making and using themEP2479267A1Dec 21, 2007Jul 25, 2012Verenium CorporationAmylases and glucoamylases, nucleic acids encoding them and methods for making and using themEP2548954A1Feb 14, 2007Jan 23, 2013Verenium CorporationXylanases, nucleic acids encoding them and methods for making and using themEP2548955A1Feb 14, 2007Jan 23, 2013Verenium CorporationXylanases, nucleic acids encoding them and methods for making and using themEP2548956A1Feb 14, 2007Jan 23, 2013Verenium CorporationXylanases, nucleic acids encoding them and methods for making and using themEP2617728A2Sep 21, 2007Jul 24, 2013Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themEP2617729A2Sep 21, 2007Jul 24, 2013Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themEP2617815A2Sep 21, 2007Jul 24, 2013Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themEP2617816A2Sep 21, 2007Jul 24, 2013Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themEP2617817A2Sep 21, 2007Jul 24, 2013Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themEP2617819A2Sep 21, 2007Jul 24, 2013Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themEP2617820A2Sep 21, 2007Jul 24, 2013Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themEP2617821A2Sep 21, 2007Jul 24, 2013Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themEP2617823A2Sep 21, 2007Jul 24, 2013Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themEP2620495A2Sep 21, 2007Jul 31, 2013Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themEP2698374A1May 20, 2010Feb 19, 2014Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themEP2708602A2Aug 1, 2008Mar 19, 2014Verenium CorporationXylanases, nucleic acids encoding them and methods for making and using themEP2853593A1Mar 8, 2004Apr 1, 2015DSM IP Assets B.V.Hydrolases, nucleic acids encoding them and mehods for making and using themEP2886658A1Mar 10, 2006Jun 24, 2015BASF Enzymes LLCLyase enzymes, nucleic acids encoding them and methods for making and using themEP2949756A2Jan 13, 2006Dec 2, 2015BP Corporation North America Inc.Cellulases, nucleic acids encoding them and methods for making and using themEP3023498A1Mar 8, 2004May 25, 2016BASF Enzymes LLCAmylases, nucleic acids encoding them and methods for making and using themEP3101128A1Dec 21, 2007Dec 7, 2016BASF Enzymes LLCAmylases and glucoamylases, nucleic acids encoding them and methods for making and using themEP3153580A2Mar 7, 2007Apr 12, 2017BASF Enzymes LLCAldolases, nucleic acids encoding them and methods for making and using themWO1997012030A1 *Sep 6, 1996Apr 3, 1997Nanogen, Inc.Apparatus and methods for active programmable matrix devicesWO1998010277A1 *Jul 31, 1997Mar 12, 1998Nanogen, Inc.Apparatus and methods for active biological sample preparationWO1999006593A1 *Jul 28, 1998Feb 11, 1999Sarnoff CorporationSolid support with attached moleculesWO1999042558A1 *Feb 11, 1999Aug 26, 1999Nanogen, Inc.Advanced active devices and methods for molecular biological analysis and diagnosticsWO2000032744A1 *Nov 22, 1999Jun 8, 2000Nanogen, Inc.Apparatus and methods for transport of charged biological materialsWO2000067007A2 *May 3, 2000Nov 9, 2000Motorola, Inc.Method and apparatus for obtaining electric field-enhanced bioconjugationWO2000067007A3 *May 3, 2000Jan 25, 2001Motorola IncMethod and apparatus for obtaining electric field-enhanced bioconjugationWO2004087303A1 *Nov 26, 2003Oct 14, 2004Fujitsu LimitedTarget detecting device and target capturer, molecule adsorption/desorption device and molecule adsoprtion/desoption method, and protein detecting device and protein detecting methodWO2004090099A2Apr 2, 2004Oct 21, 2004Diversa CorporationPectate lyases, nucleic acids encoding them and methods for making and using themWO2005021714A2Aug 11, 2004Mar 10, 2005Diversa CorporationLaccases, nucleic acids encoding them and methods for making and using themWO2006009676A2Jun 14, 2005Jan 26, 2006Diversa CorporationCompositions and methods for enzymatic decolorization of chlorophyllWO2006101584A2Jan 13, 2006Sep 28, 2006Diversa CorporationCellulases, nucleic acids encoding them and methods for making and using themWO2007013896A2May 16, 2006Feb 1, 2007Plexxikon, Inc.Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitorsWO2008036863A2Sep 21, 2007Mar 27, 2008Verenium CorporationPhospholipases, nucleic acids encoding them and methods for making and using themWO2008036916A2Sep 21, 2007Mar 27, 2008Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themWO2008080093A2Dec 21, 2007Jul 3, 2008Verenium CorporationAmylases and glucoamylases, nucleic acids encoding them and methods for making and using themWO2008095033A2Jan 30, 2008Aug 7, 2008Verenium CorporationEnzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using themWO2009045627A2Aug 1, 2008Apr 9, 2009Verenium CorporationXylanases, nucleic acids encoding them and methods for making and using themWO2009088949A1Dec 31, 2008Jul 16, 2009Verenium CorporationTransferases and oxidoreductases, nucleic acids encoding them and methods for making and using themWO2010025395A2Aug 28, 2009Mar 4, 2010Verenium CorporationHydrolases, nucleic acids encoding them and methods for making and using themWO2010135588A2May 20, 2010Nov 25, 2010Verenium CorporationPhytases, nucleic acids encoding them and methods for making and using themWO2011038360A1Sep 27, 2010Mar 31, 2011Signature Genomics Laboratories LlcMultiplex (+/-) stranded arrays and assays for detecting chromosomal abnormalities associated with cancer and other diseasesWO2011046812A1Oct 8, 2010Apr 21, 2011Verenium CorporationPhospholipases, nucleic acids encoding them and methods for making and using themWO2011046815A1Oct 8, 2010Apr 21, 2011Bunge Oils, Inc.Oil degumming methodsWO2011048495A1Oct 19, 2010Apr 28, 2011Stichting Het Nederlands Kanker InstituutPredicting benefit of anti-cancer therapy via array comparative genomic hybridizationWO2011048498A2Oct 19, 2010Apr 28, 2011Stichting Het Nederlands Kanker InstituutDifferentiation between brca2-associated tumours and sporadic tumours via array comparative genomic hybridizationWO2011048499A1Oct 19, 2010Apr 28, 2011Stichting Het Nederlands Kanker InstituutPredicting response to anti-cancer therapy via array comparative genomic hybridizationWO2012038837A2Sep 20, 2011Mar 29, 2012Stichting Het Nederlands Kanker InstituutMethods for predicting response to anti-cancer therapy in cancer patientsWO2012051055A2Oct 6, 2011Apr 19, 2012Bp Corporation North America Inc.Variant cbh i polypeptidesWO2016164641A1Apr 7, 2016Oct 13, 2016Plexxikon Inc.Compounds and methods for kinase modulation, and indications thereforWO2017019804A2Jul 27, 2016Feb 2, 2017Plexxikon Inc.Compounds and methods for kinase modulation, and indications therefor* Cited by examinerClassifications U.S. Classification435/6.11, 436/807, 422/68.1, 436/809, 536/25.4, 436/94, 436/72, 422/520International ClassificationG01N33/53, C12Q1/68, C12N15/09Cooperative ClassificationY10T436/143333, Y10S436/807, Y10S436/809, C12Q1/6825, C12Q1/6837, B01J2219/00653European ClassificationC12Q1/68B2H, C12Q1/68B10ALegal EventsDateCodeEventDescriptionMar 2, 1995ASAssignmentOwner name: HITACHI, LTD., JAPANFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:OKANO, KAZUNORI;KAMBARA, HIDEKI;REEL/FRAME:007374/0011Effective date: 19930210Jan 4, 1999FPAYFee paymentYear of fee payment: 4Dec 30, 2002FPAYFee paymentYear of fee payment: 8Jan 31, 2007REMIMaintenance fee reminder mailedJul 18, 2007LAPSLapse for failure to pay maintenance feesSep 4, 2007FPExpired due to failure to pay maintenance feeEffective date: 20070718RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services